Breckenridge Announces Final Approval of its ANDA for Pomalidomide Capsules (generic for Pomalyst®)
Breckenridge Pharmaceutical, Inc. announced today that the U.S. Food and Drug Administration has approved Breckenridge’s Abbreviated New Drug Application for Pomalidomide Capsules (generic for Pomalyst®).
Towa completes acquisition of Esteve’s Generic Division
Berlin, CT January 31, 2020 – Breckenridge Pharmaceutical, Inc. announced today that Towa Pharmaceutical Co., Ltd. has completed its acquisition of Esteve’s generics division, including Breckenridge.
